Governance Dashboard
How every registry entry is tagged across regulatory status, evidence level, and audience target.
Every entry in the ASH registries carries governance metadata: a regulatory status (where the claim sits between FDA-cleared and historical), an evidence level (RCT vs case series vs preclinical), and one or more audience targets (clinician, researcher, patient). This page renders the distribution live, so the editorial state of the knowledge base is visible without having to ask anyone.
Complementary to the Coverage Map (tier-focused) and the Atlas by Organ System (anatomy-focused). The dashboard below counts tags, not interpretations \u2014 buckets labelled "(untagged)" are registry entries that still need governance backfill.
Live registry counts
Pulled from lib/*-registry.ts at render time. Total across all five registries: 792 entries.
Distribution by regulatory status
How each registry breaks down across the seven RegulatoryStatus buckets defined in lib/types/governance.ts. Bar length is relative to the largest bucket within a registry.
Conditions
n = 199- FDA-cleared device3
- Off-label, RCT-supported10
- Investigational human186
Compounds
n = 201- Off-label, RCT-supported9
- Preclinical / mechanistic192
RCTs
n = 169- FDA-cleared device52
- Off-label, RCT-supported80
- Investigational human12
- Preclinical / mechanistic14
- Historical / educational1
- Non-clinical science7
- Not recommended3
Biographies
n = 68- Historical / educational37
- Untagged (governance backlog)31
Jurisdictions
n = 155- Non-clinical science105
- Untagged (governance backlog)50
Distribution by evidence level
GRADE + Oxford CEBM hierarchy. Higher tiers (FDA, systematic review, RCT) at the top of each card; mechanistic and historical at the bottom.
Conditions
n = 199- FDA-cleared context3
- Systematic review1
- RCT7
- Cohort / case series11
- Case report165
- Mechanistic12
Compounds
n = 201- FDA-cleared context9
- Systematic review1
- Preclinical (in vivo)20
- In vitro114
- Mechanistic52
- Expert consensus5
RCTs
n = 169- Systematic review17
- Meta-analysis5
- RCT20
- Guideline5
- Cohort / case series51
- Case report33
- Preclinical (in vivo)15
- In vitro1
- Mechanistic9
- Expert consensus4
- Insufficient9
Biographies
n = 68- Historical37
- Untagged31
Jurisdictions
n = 155- Insufficient105
- Untagged50
Distribution by audience target
Audience tags are multi-valued: a single entry can be tagged for both clinicians and researchers, in which case it is counted in each bucket. Totals here may therefore exceed the row's n.
Conditions
n = 199- Clinician199
- Researcher186
- Patient13
Compounds
n = 201- Clinician144
- Researcher201
- Regulatory1
RCTs
n = 169- Clinician138
- Researcher168
- Patient2
- Institution9
- Regulatory6
Biographies
n = 68- Researcher37
- Mixed37
- Untagged31
Jurisdictions
n = 155- Institution105
- Regulatory105
- Untagged50
Related transparency views
Each of the views below answers a different question about the same underlying registries. Together they form ASH's public editorial dashboard.
- Coverage Map \u2014 tier-focused view: how many conditions sit at Tier A (FDA-cleared), Tier B (off-label, RCT-supported), Tier C (investigational).
- Atlas by Organ System \u2014 anatomy-focused view: every condition organised across twelve organ-system categories.
- PMID Audit Status \u2014 citation-integrity view: which PMIDs in hand-built registries have been verified against PubMed.
- Transparency and Trust \u2014 narrative overview of ASH's editorial commitments, correction policy, and disclosure practices.